# EDGAR Filing Document

**Accession Number:** 0001819113
**File Stem:** 0001819113-23-000016
**Filing Date:** 2023-3
**Character Count:** 4540
**Document Hash:** 032da6716c058bd4ecaac22b4d329f48
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001819113-23-000016.hdr.sgml**: 20230313

**ACCESSION NUMBER**: 0001819113-23-000016

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20230313

**ITEM INFORMATION**: Other Events

**FILED AS OF DATE**: 20230313

**DATE AS OF CHANGE**: 20230313

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Science 37 Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001819113
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
- **IRS NUMBER:** 844278203
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39727
- **FILM NUMBER:** 23725624

**BUSINESS ADDRESS:**
- **STREET 1:** 800 PARK OFFICES DRIVE
- **STREET 2:** SUITE 3606
- **CITY:** RESEARCH TRIANGLE PARK
- **STATE:** NC
- **ZIP:** 27709
- **BUSINESS PHONE:** (984) 377-3737

**MAIL ADDRESS:**
- **STREET 1:** 800 PARK OFFICES DRIVE
- **STREET 2:** SUITE 3606
- **CITY:** RESEARCH TRIANGLE PARK
- **STATE:** NC
- **ZIP:** 27709

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Lifesci Acquisition II Corp.
- **DATE OF NAME CHANGE:** 20200723

?xml version="1.0" ? snce-20230313

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d) OF THE**

**SECURITIES EXCHANGE ACT OF 1934**

Date of Report (Date of earliest event reported): **March 13, 2023**

**SCIENCE 37 HOLDINGS, INC.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-39727** | **84-4278203** |
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |

---

---

| | |
|:---|:---|
| **800 Park Offices Drive, Suite 3606**<br>**Research Triangle Park, NC** | **27709** |
| (Address of principal executive offices) | (Zip Code) |

---

**(984) 377-3737**

Registrant's telephone number, including area code

**Not Applicable**

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which**<br> **registered** |
| Shares of Common stock, par value $0.0001 per share | **SNCE** | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 8.01&nbsp;&nbsp;&nbsp;&nbsp;Other Events.**

Science 37 Holdings, Inc. (the "Company") is aware of the closure of Silicon Valley Bank ("SVB") by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation as receiver. The Company currently holds over 95% of its cash and cash equivalents at large U.S. banking institutions that are unrelated to SVB. As of December 31, 2022, the Company had approximately $108 million in cash and cash equivalents.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| | | **Science 37 Holdings, Inc.** | **Science 37 Holdings, Inc.** |
| Date: | March 13, 2023 | By: | /s/ Christine Pellizzari |
|  |  | Name: | Christine Pellizzari |
|  |  | Title: | Chief Legal Officer |

---